Navigation Links
FASEB announces 2014 Science Research Conference: Lipid and Lipid Regulated Kinases in Cancer
Date:1/22/2014

Bethesda, MD This 2014 FASEB Science Research Conference focuses on recent advances in our understanding of lipid-regulated signal transduction cascades, lipid mediators, and lipid targets that are known to play major roles in the initiation and progression of human cancers.

This FASEB Conference brings together physician-scientists, basic scientists and scientists from industry for presentations, discussion, and collaboration to broaden our understanding of how these pathways drive cancer, and to explore these and the associated signaling network as targets for cancer therapy. There are numerous challenges in this relatively young, yet rapidly evolving field. Perhaps most critical is understanding the molecular mechanisms by which lipid effectors modulate mitogenesis, cell cycle regulation, cell death and differentiation in transformed cells, and elucidating how intracellular generation of bioactive lipids is altered in transformed cells and contributes to cancer progression.

This meeting strives to provide researchers with an update on current basic, mechanistic discoveries, and to place these discoveries in the proper translational and clinical context. Meeting topics include: The phosphoinostide pathway and its effectors including the protein kinase C (PKC) isozymes, Rho family GTPases, and Ras; modification of membrane phosphoinostides by PI3K, activation of the Akt isozymes and their downstream targets such as mTOR; new phospholipases and the characterization of novel effectors of bioactive products such as COX2 and the isoprostanes; and lipid post-translational modifications of the Ras oncogene and other GTPases that contribute to their transforming activities.


'/>"/>

Contact: Robin Crawford
src@faseb.org
301-634-7010
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1

Related biology news :

1. FASEB announces 2014 Science Research Conference: Folic Acid, Vitamin B12 and One Carbon Metabolism
2. FASEB announces 2014 SRC: Phospholipid Cell Signaling & Metabolism in Inflammation & Cancer
3. FASEB announces 2014 Science Research Conference: Molecular Biophysics of Membranes
4. FASEB announces 2014 SRC: Translational Neuroimmunology: From Mechanisms to Therapeutics
5. FASEB announces 2014 Science Research Conference: Nutrient Sensing and Metabolic Signaling
6. FASEB announces 2014 Science Research Conference: Retinal Neurobiology and Visual Processing
7. FASEB announces 2014 Science Research Conference: Virus Structure and Assembly
8. FASEB announces 2014 Science Research Conference: Protein Folding in the Cell
9. FASEB announces 2014 Science Research Conference: 2nd International Conference on Retinoids
10. FASEB announces SRC: Molecular Mechanisms of Intestinal Lipid Transport & Metabolism
11. FASEB announces 2014 SRC: Protein Phosphorylation, Cellular Plasticity & Signaling Rewiring
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2015)... YORK , April 14, 2015  HYPR ... IDentity Online (FIDO ® ) Alliance tm , ... specifications. FIDO members commit to share technology and ... methods that are interoperable, more secure and private, ... enable biometric identity verification that protects sensitive user ...
(Date:4/9/2015)... Synaptics Inc. (NASDAQ: SYNA ), a leading ... will report financial results for the third quarter of ... close of market. The company will host a corresponding ... PT (5:00 p.m. ET), during which management may discuss ... live call, analysts and investors should dial 888-438-5524 (conference ...
(Date:4/2/2015)... According to preliminary estimates Fingerprint ... higher than 125 MSEK. This exceeds the guidance provided ... revenues for Q1 2015 would be in line with ... 2014. The operating result for the first quarter is ... report will as previously communicated be published on May ...
Breaking Biology News(10 mins):HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3Synaptics to Report Third Quarter Results on April 23 2Fingerprint Cards Revises Revenues for Q1 2015 2
... Reusing the major greenhouse gas carbon dioxide (CO2) from industrial ... environment is on the verge of becoming a commercial ... in the U.S. are leading the way, according to an ... newsmagazine of the American Chemical Society. Alex Scott, C&EN,s ...
... contact during early infancy may be a key to early ... National Institute of Mental Health (NIMH), part of the National ... Nature , the study reveals the earliest sign of developing ... within the first two to six months of life. ...
... Texas Medical Branch at Galveston have discovered one of the ... the Journal of Biological Chemistry . While ... cardiomyopathy develops is not well understood, other than that it ... a family of enzymes that controls the functions of other ...
Cached Biology News:Earliest marker for autism found in young infants 2Earliest marker for autism found in young infants 3Research reveals possible cause of diabetic cardiomyopathy 2
(Date:4/23/2015)... NY , April 23, 2015 /PRNewswire/ - Crystal ... an Executive Informational Overview ® (EIO) on Aeterna ... 52-page report is available on Crystal Research Associates, website ... on Aeterna Zentaris, website at www.aezsinc.com . ... into a specialty biopharmaceutical company in oncology, endocrinology, and ...
(Date:4/23/2015)... 2015 Delpor, Inc. (Delpor), a biotechnology ... United States Patent and Trademark Office has issued 2 ... technology. US Pat. No. 8,986,727 was issued on ... delivery device for the sustained release of therapeutic ... the sustained (zero-order) release of large and small molecules ...
(Date:4/22/2015)... -- Sangamo BioSciences, Inc. (NASDAQ: SGMO ) today reported ... For the first quarter ended March 31, 2015, ... or $0.08 per share, compared to a net loss ... same period in 2014. As of March 31, 2015, ... interest receivable of $226.1 million. Revenues for ...
(Date:4/22/2015)... SEATTLE , April 22, 2015   ... startup, today announced $1.6M in Series A financing ... investor. The funding helps accelerate consumer and employer ... scores covering surgeries at over 4,800 U.S. hospitals. ... surgery, you are probably very concerned about choosing ...
Breaking Biology Technology:Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on Aeterna Zentaris Inc. 2Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on Aeterna Zentaris Inc. 3Delpor, Inc. Announces the Issuance of 2 New US Patents Based on its Nanopore Technology which Enables the Sustained Release of Drugs from a Small Implant Device 2Delpor, Inc. Announces the Issuance of 2 New US Patents Based on its Nanopore Technology which Enables the Sustained Release of Drugs from a Small Implant Device 3Sangamo BioSciences Reports First Quarter 2015 Financial Results 2Sangamo BioSciences Reports First Quarter 2015 Financial Results 3Sangamo BioSciences Reports First Quarter 2015 Financial Results 4Sangamo BioSciences Reports First Quarter 2015 Financial Results 5Sangamo BioSciences Reports First Quarter 2015 Financial Results 6Sangamo BioSciences Reports First Quarter 2015 Financial Results 7Sangamo BioSciences Reports First Quarter 2015 Financial Results 8MPIRICA Health Inc. Secures $1.6M to Promote FICO-Like Quality Scores for Surgeries 2
... Sciences Inc., a privately held,biopharmaceutical company that specializes ... pharmaceuticals, today reported,that enrollment has begun for a ... Iluvien(TM) in patients with bilateral geographic atrophy (GA) ... The pilot study will ...
... Dec. 11 /PRNewswire-FirstCall/ - GeneNews Limited (TSX: GEN), ... for the early detection of diseases and personalized ... into a agreement allowing Centocor Research & Development, ... genomic biomarker program. Additional terms of the agreement ...
... LOURES, Portugal, December 11 Hovione announced today,that it ... Ingredients (API) site in Ireland. This site manufactures,intermediates for ... The site has had a number of ... & Welch, Warner Lambert, Pfizer and now Hovione. Over,the ...
Cached Biology Technology:Alimera Sciences Begins Pilot Study to Assess Safety and Efficacy of Iluvien(TM) in Patients With Bilateral Geographic Atrophy Due to AMD 2GeneNews provides Centocor access to its osteoarthritis program 2Hovione Buys Pfizer's Loughbeg API Facility 2Hovione Buys Pfizer's Loughbeg API Facility 3
FITC~Bovine Serum Albumin...
, Premium quality synthesis and purification , You provide the sequence, we'll do the rest , Rigorous quality control , Your choice of purification method, amount and format , Available annealed...
GEL FILTRATION CAL KIT HMW, 1 EA. *Category: Gel Filtration Gels....
Human SDNSF/MCFD2 Biotinylated Affinity Purified PAb...
Biology Products: